Topic Archives: Celgene (CELG)

[Ed. Note: Dr. KSS writes about medicine and biotech stocks for the Irregulars. He has agreed to our trading restrictions, and his words and opinions are his own. You can see all of his past articles here.] “All non-denial denials. They doubt our ancestry, but they don’t say the story isn’t accurate.” —-from All the President’s […]

[Ed. Note: Dr. KSS writes for the Irregulars about medicine and biotech stocks. He choses his own topics, and his words and opinions are his own. He has agreed to our trading restrictions. Enjoy!] In his smoky baritone, singer Stuart Staples of British midlands musical act Tindersticks is bemoaning how he suspects the woman he […]

[ed note: Michael Jorrin, who I like to call “Doc Gumshoe”, is a longtime medical writer (not a doctor) who shares his thoughts with us from time to time, generally on non-financial topics in health and medicine (as today, though, he mentions a couple publicly traded companies). His words and opinions are his own.] The […]

[Ed. Note: Dr. KSS writes about medicine and biotech stocks for the Gumshoe Irregulars. He has agreed to our trading restrictions, he chooses his own topics, and his words and opinions are his own. Enjoy!] OK, admit it….how many of you have seen the campy films of Baltimore director John Waters? The ones starring the […]

[ed note: Dr. KSS is a paid contributor to Stock Gumshoe who writes about biotech stocks for (and discusses them with) the Irregulars. He chooses his own topics, and his words and opinions are his alone. Enjoy!] Greetings fellow Irregulars!  You’ve all been waiting for it….our first-ever annual ceremony in which we look back on […]

[Ed. Note: Dr. KSS writes about medicine and biotech stocks for the Irregulars. His words and opinions are his own, and he has agreed to our trading restrictions.] Want to see something really cool? A hot video clip from a steamy biotech thriller? Watch this. Better yet, when you pull up the video viewing frame, […]

[ed. note: Dr. KSS writes about biotech stocks for the Irregulars. He has agreed to our trading restrictions, but he chooses his own topics and his words and thoughts are his own] According to new SEC filings, Cellceutix President, co-founder and Chief Scientific Officer Krishna Menon has recently settled what should probably be regarded as […]

Comments

  • Avatar

    What a lovely experience; customer service is excellent as the previous reviewers stated. I needed to cancel my subscrip...

  • Avatar

    After going thoroughly over their trading methodology, it is both sound and makes sense. One aspect of their trading ...

  • Avatar

    I am from Kenya, in africa.i have read about the “No. 1 Stock in 2019” — $3 “Single Stock Retirement Plan” tra...

  • Avatar

    Ok Thanks Julie; I thought you had to pair the trade as separate transactions yourself and that's why I mentioned how t...

  • Avatar

    Took the words right out of my mouth. Kind of wished I had got some of SPOT when it ticked under 125 a couple of weeks ...

  • Avatar

    ARK Genomic Revolution Multi-Sector ETF—ARKG This one has EDIT, CELG, NTLA, CRSP......

  • Avatar

    EDIT and CELG are Motley Fool favorites also. Lost money on CELG....

  • Avatar

    Motley Fool has been touting BLUE for a while. They've also been touting Celgene (CELG) which hasn't done a whole lot si...

  • Gr8Full!

    $CELG - What caused Celgene's latest snafu?; Judge shreds Shkreli (YUCK) defense, leaves him exposed to hard time T...

  • Avatar

    $SRNE LONG Juno acquisition bodes well for Sorrento, says H.C. Wainwright H.C. Wainwright analyst Raghuram Selvara...

  • SoGiAm

    $BIOC long - Form SC 13D/A / Amended General Statement of Beneficial Ownership http://ir.biocept.com/secfiling.cfm?fil...

  • Avatar

    Recent deal maker with Celgene (CELG) Jounce to IPO. http://marketexclusive.com/worth-following-celgene-corporation-n...

  • Avatar

    Given its now large size and similar reliance on a single category of drugs, do you see Celgene ($CELG) headed down the...

  • Avatar

    Celgene (CELG) on the hunt ? http://endpts.com/analyst-celgene-looks-ready-to-pop-a-new-multiple-myeloma-deal/?utm_me...

  • Avatar

    Celgene (CELG) plots speedy FDA filing on blood cancer drug with partner Agios (AGIO). http://www.xconomy.com/boston/...

  • Avatar

    Interesting story on Celgene (CELG) and their drug Thalomid. http://www.bloomberg.com/news/articles/2016-08-22/from-n...

  • Avatar

    SRNE news today. Hires former CMO of Celgene (CELG) http://finance.yahoo.com/news/dr-jerome-zeldis-m-d-130000130.htm...

  • SoGiAm

    $CELG ncp - Analyst Brian Abrahams from Jefferies reiterated a Buy rating on Celgene ($CELG) 4.6 stars Analyst Averag...

  • SoGiAm

    #CELG via Tipranks.com - Analyst Eric Schmidt from Cowen & Co. reiterated a Buy rating on Celgene (CELG), with a $15...

  • Avatar

    Celgene (CELG) signs big deal with 2.56 billion dollar deal with Jounce Therapeutics. This is quite a big deal. http://...

  • SoGiAm

    $CELG long- tipranks.com Analyst Ying Huang from Merrill Lynch reiterated a Buy rating on Celgene (CELG), with a $125 p...

  • sogiam

    Analysts Chime In on Depomed Inc (DEPO) and Celgene Corporation (CELG) Following Starboard’s Activism Announcement and...

  • Dr. KSS MD PhD

    An update regarding investigational drug RPC-4046. Recall our prior column on Receptos: readers who went long this st...

  • Avatar

    Which drugs will drive valuations for Celgene (CELG) in 2016. http://marketrealist.com/2016/03/celgene-valuation-comp...

  • Avatar

    Daniels who is currently Chairman of research of Celgene (CELG) brings a lot of clout to Zafgen, excellent add. Cheer...

  • Avatar

    The best Celgene (CELG) headlines of 2015. http://www.fool.com/investing/general/2016/01/01/the-best-celgene-corporat...

  • Avatar

    Cramer 4 Biotech's to buy for 2016 include Gilead (GILD) and Celgene (CELG). http://www.cnbc.com/2015/12/23/cramer-bi...

  • Avatar

    CELGENE (CELG) Research. A Holiday Gift; Settling Revlimid Patent Overhang - Reiterate BUY and $163 PT Investme...

  • Avatar

    Celgene (CELG) Blood cancer drug could be a big winner. http://blogs.barrons.com/stockstowatchtoday/2015/12/07/celgene-...

  • Avatar

    Baron's top 10 for 2016 includes Celgene (CELG). http://finance.yahoo.com/news/barrons-recap-top-picks-2016-231304846.h...

  • Avatar

    Positive article on Celgene (CELG), what Doc Kss has been telling us for a long time. CELG possibly one of the best run ...

  • Avatar

    JP Morgan goes to overweight on Celgene (CELG). smaller Larger By Ben Levisohn In upgrading Celgene (CELG) to...

  • Avatar

    Interesting Baron's article. Gilead Science, How bad can it get? Email Print smaller Larger By Ben Levisohn ...

  • Avatar

    Celgene (CELG) one of Jefferies top picks. http://247wallst.com/healthcare-business/2015/09/11/jefferies-starts-coverag...

  • Anamorph

    Adam Feuerstein's column on Monday's volatility (pretty sure he could be describing most Gummies here as well): "I wi...

  • Avatar

    Nice article on Celgene (CELG). http://education.investors.com/ibd-stock-analysis/082115-767715-biotech-celgene-juno-th...

  • Avatar

    Nice summary of Celgene (CELG). http://seekingalpha.com/article/3335345-celgene-new-deals-creating-more-compelling-inve...

  • Avatar

    Link did not work on Celgene (CELG) licensing deals and valuation on above.Try this one. Normally do not like Seeking Al...

  • Avatar

    Interesting perspective on Celgene (CELG) latest licensing deals and valuation. I tend to agree with this article for th...

  • Avatar

    Thoughts on Celgene (CELG) on boosting share repurchase plan. http://www.investopedia.com/stock-analysis/062215/celgene...

  • Avatar

    Celgene (CELG) announces 4 billion dollar stock buy back. http://finance.yahoo.com/news/celgene-announces-additional-4-...

  • Avatar

    Interesting on Celgene (CELG) and CAR-T take. http://www.investopedia.com/stock-analysis/060815/celgene-takes-step-back...

  • Dr. KSS, MD PhD

    Glenn and Om had recently brought up Momenta as a play on the biosimilars space. What are biosimilars? They can be...

  • Avatar

    From SA: Luspatercept Fast Track'd for beta thalassemia The FDA designates luspatercept for Fast Track review for th...

  • Avatar

    What Doc Kss has been telling us about Celgene (CELG) all along. http://www.cnbc.com/id/102676161?__source=yahoo%7Cfina...

  • Avatar

    Great to have some conservative Biotech in your lineup like Celgene (CELG). Martin Zweig - Conservative Growth Invest...

  • Avatar

    Kris, GBIM looks very interesting with Gileads (GILD) backing in HBV and also a partnership with Celgene (CELG) that loo...

  • Avatar

    Celgene (CELG) and Activus (ACT) set to join S&P 100. http://finance.yahoo.com/news/celgene-kinder-morgan-actavis-set-2...

  • Avatar

    Celgene (CELG) getting some action. http://www.cnbc.com/id/102492475?__source=yahoo%7cfinance%7cheadline%7cheadline%7cs...

  • Avatar

    Celgene (CELG) news. http://www.investopedia.com/articles/investing/022615/celgenes-approval-means-sales-could-surge.as...

  • Avatar

    More good new from Celgene (CELG) this morning. Long CELG. http://finance.yahoo.com/news/celgene-announces-positive-rec...

  • Avatar

    Celgene (CELG) is a machine.They just keep spitting out good news on their drugs. http://www.rttnews.com/2445565/celgen...

  • Avatar

    Wow, Celgene (CELG) expects to triple profits by 2020. http://247wallst.com/healthcare-business/2015/01/12/celgene-expe...

  • Avatar

    Nice article on Celgene (CELG) today at Barrons.As Doc has said this company is simply loaded across the board with gre...

  • Dr. KSS, MD PhD

    An extemporaneous shout-out to readers here about a topic that comes up now and again: Celgene $CELG. I have owned share...

  • Avatar

    Thanks, doc. I'll definitely try to make time when I can. I'll be traveling a lot more, though, and it's sometimes har...

  • Dr. KSS, MD PhD

    Celgene $CELG CEO has made major transactions in his company's shares per new SEC filing: http://ir.celgene.com/secfi...

  • Dr. KSS, MD, PhD

    Celgene (CELG) is planning a 2:1 stock split this summer. A great company with room to run,...

  • Avatar

    Morgan Stanley has 44 stocks on takeover target radar, including 3 biopharma - Celgene (CELG), Regeneron (REGN) and Ale...

  • This site and Stock Gumshoe publications and authors do not offer individual financial, investment, medical or other advice. Nothing on this site should ever be considered to be personal advice, research or an invitation to buy or sell any securities. We also make mistakes and bad decisions sometimes, and our reasoning or data should be checked against trusted sources before they inform your investing decisions. Choices regarding how to invest your money or otherwise manage your life or finances are yours, we share only our analysis and opinion and all authors or commenters are individually responsible for the words and opinions they share here. Please read our important disclaimers and policies. Stock Gumshoe is supported by subscribers and by sponsors and advertisers. Stock Gumshoe's employee authors will disclose holdings in any stock covered at time of publication and will not trade in any stocks written about for at least three days after publication. Please see below for complete disclosure, disclaimer and policy information.

    Connect with Travis

    website designed by Gravity Switch